SoftOx Solutions AS — Capital/Financing Update 2024

Jan 16, 2024

SoftOx Solutions AS Update financial restructuring

SoftOx Solutions AS Update financial restructuring

OSLO – 16th of January 2024:

Reference is made to SoftOx (the Company) press release of 11th of January 2024 where the Company announced on-going work to restructure the financial situation.

The Company is in process of reaching an agreement with the lenders in the NOK 40 million convertible loan with due date of 15th of January 2024 to prolong the due date until 1st of April 2024 on certain conditions, proposed by one of the largest holders in the loan.

So far, 88% of the holders of the convertible loan have accepted the proposal. The company will revert with further information after all lenders have given their feedback.

SoftOx Solutions AS

Mail: ir@soft-ox.com

Phone: (+47) 977 50 071 (Chairman of the Board Geir Almås)

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Medtech and

clinical-stage pharmaceutical company based in Oslo, Norway, with the goal of reducing

the spread of infection and emergence of antimicrobial resistance.

For more information on SoftOx, visit www.soft-ox.com